QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
NASDAQ:VINC

Vincerx Pharma Insider Trades

$6.77
-0.19 (-2.73%)
(As of 01/27/2022 04:00 PM ET)
Add
Compare
Today's Range
$6.61
$7.05
50-Day Range
$6.77
$12.56
52-Week Range
$6.23
$26.75
Volume
112,588 shs
Average Volume
149,766 shs
Market Capitalization
$142.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Vincerx Pharma (NASDAQ:VINC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
49.00%

Number Of
Insiders Buying
(Last 12 Months)
6

Amount Of
Insider Buying
(Last 12 Months)
$409.74 K

Number Of
Insiders Selling
(Last 12 Months)
0

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get VINC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vincerx Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Vincerx Pharma (NASDAQ VINC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/22/2021Ahmed Md HamdyCEOBuy6,450$10.02$64,629.00  
12/22/2021Alexander A SeelenbergerCFOBuy2,417$10.34$24,991.78  
12/22/2021Laura I BushnellDirectorBuy2,402$10.48$25,172.96  
12/22/2021Tom C ThomasInsiderBuy1,000$10.23$10,230.00  
8/4/2021Raquel E IzumiInsiderBuy1,000$11.96$11,960.00  
6/29/2021Andrew I. McdonaldDirectorBuy20,000$12.38$247,600.0020,000  
6/29/2021Tom C ThomasInsiderBuy2,000$12.58$25,160.00205,522  
(Data available from 1/1/2013 forward)












Vincerx Pharma (NASDAQ:VINC) Insider Trade Frequently Asked Questions

Who is on Vincerx Pharma's Insider Roster?

The list of insiders at Vincerx Pharma includes Ahmed Md Hamdy, Alexander A Seelenberger, Andrew I. Mcdonald, Laura I Bushnell, Raquel E Izumi, and Tom C Thomas.Learn more on VINC's insiders

What percentage of Vincerx Pharma stock is owned by insiders?

49.00% of Vincerx Pharma stock is owned by insiders. Learn more on VINC's insider holdings

Which Vincerx Pharma insiders have been buying company stock?

The following insiders have purchased Vincerx Pharma stock in the last 24 months: Ahmed Md Hamdy ($64,629.00), Alexander A Seelenberger ($24,991.78), Andrew I. Mcdonald ($247,600.00), Laura I Bushnell ($25,172.96), Raquel E Izumi ($11,960.00), and Tom C Thomas ($35,390.00).

How much insider buying is happening at Vincerx Pharma?

Insiders have purchased a total of 35,269 Vincerx Pharma shares in the last 24 months for a total of $409,743.74 bought.

This page was last updated on 1/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.